Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BMP Sunstone Acquires Pediatric Drug Company

publication date: Jul 18, 2008

BMP Sunstone Corporation signed a non-binding letter of intent to acquire 75% of Zhangjiakou Shengda Pharmaceutical Co., Ltd, a subsidiary of the Zhangjiakou Pharmaceutical Group, at a price of up to 30.0 million RMB ($4.4 million). For BMP Sunstone, the logic behind the acquisition is provided by the pediatric pharmaceutical focus of Shengda. Shengda concentrates on antibiotic R&D and boasts 75 SFDA product licenses. BMP Sunstone said Shengda’s products will extend BMP’s GoodBaby line of OTC and prescription products. More details...

Stock Symbol: (NSDQ: BJGP)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here